Enveda Biosciences Raises $55M in Series B2 Funding to Advance AI-powered Drug Discovery Platform
Enveda Biosciences, a Colorado-based biotech company that leverages the power of AI to develop new plant-based medicines, has secured $55M in a series B2 financing round to advance its breakthrough AI-powered drug discovery platform.
Founded in 2019 by Viswa Colluru, PhD, the startup’s latest funding round was spearheaded by new investors Premji Invest - US and LINGOTTO INVESTMENTS Fund, with par... moreEnveda Biosciences Raises $55M in Series B2 Funding to Advance AI-powered Drug Discovery Platform
Enveda Biosciences, a Colorado-based biotech company that leverages the power of AI to develop new plant-based medicines, has secured $55M in a series B2 financing round to advance its breakthrough AI-powered drug discovery platform.
Founded in 2019 by Viswa Colluru, PhD, the startup’s latest funding round was spearheaded by new investors Premji Invest - US and LINGOTTO INVESTMENTS Fund, with participation from Microsoft and The Nature Conservancy, alongside initial investors True Ventures, FPV Ventures, Level Ventures, and Kinnevik.
